Concepedia
Statistics
Publications
3
Citations
147
H-Index
Active since
2021
Affiliations
Peking University(Current)
Shenzhen Bay Laboratory
Xiaoyi Wei is an author at Peking University specializing in antibody engineering, immunotherapy, and immunology.
Publications per year
2021–2022
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL
Lijun Zhao, Shuhong Li, Xiaoyi Wei et al. · Blood · 2022 · 99 citations · Full text
Life Sciences, Cancer Biology, Immunology +16
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers
Yu Cao, Xuechun Wang, Zhidong Wang et al. · ACS Synthetic Biology · 2021 · 31 citations
Pharmacy, Immunology, Oncology +17
A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy
Dong Liu, Xuexiu Qi, Xiaoyi Wei et al. · Theranostics · 2022 · 17 citations · Full text
1–3 of 3